Display options
Cite
Indovina P, Forte IM, Pentimalli F, et al. Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade. Cancers (Basel). 2020;12(7)doi: 10.3390/cancers12071866.
Indovina, P., Forte, I. M., Pentimalli, F., & Giordano, A. (2020). Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade. Cancers, 12(7), . https://doi.org/10.3390/cancers12071866
Indovina, Paola, et al. "Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade." Cancers vol. 12,7 (2020). doi: https://doi.org/10.3390/cancers12071866
Indovina P, Forte IM, Pentimalli F, Giordano A. Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade. Cancers (Basel). 2020 Jul 11;12(7). doi: 10.3390/cancers12071866. PMID: 32664483; PMCID: PMC7408838.
Copy Download .nbib Format: NLM
Share it on

Cancers (Basel). 2020 Jul 11;12(7). doi: 10.3390/cancers12071866.

Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade.

Cancers

Paola Indovina, Iris Maria Forte, Francesca Pentimalli, Antonio Giordano

Affiliations

  1. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA.
  2. Institute for High Performance Computing and Networking, National Research Council of Italy (ICAR-CNR), I-80131 Naples, Italy.
  3. Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, I-80131 Naples, Italy.
  4. Department of Medical Biotechnologies, University of Siena, I-53100 Siena, Italy.

PMID: 32664483 PMCID: PMC7408838 DOI: 10.3390/cancers12071866

[No abstract available.]

Keywords: AKT; SRC family kinases; dasatinib; drug combination; invasion; malignant mesothelioma; p27; predictive signature; receptor tyrosine kinases; treatment resistance

Conflict of interest statement

The authors declare no conflict of interest.

References

  1. Int J Mol Sci. 2018 Mar 26;19(4): - PubMed
  2. J Cell Biol. 2004 Oct 25;167(2):223-9 - PubMed
  3. Cell Rep. 2018 Dec 26;25(13):3674-3692.e10 - PubMed
  4. Thorax. 2004 May;59(5):428-33 - PubMed
  5. Front Oncol. 2018 Jun 12;8:225 - PubMed
  6. Cancer Cell. 2019 Mar 18;35(3):347-367 - PubMed
  7. J Biol Chem. 2003 Feb 14;278(7):4847-53 - PubMed
  8. Oncogene. 2004 Oct 18;23(48):7957-68 - PubMed
  9. Cell Mol Life Sci. 2018 Nov;75(22):4223-4234 - PubMed
  10. Semin Cancer Biol. 2020 Apr;61:11-22 - PubMed
  11. Clin Cancer Res. 2007 Jul 15;13(14):4191-200 - PubMed
  12. Ann Transl Med. 2017 Jun;5(11):238 - PubMed
  13. Mol Cell Biol. 2002 Apr;22(7):2025-36 - PubMed
  14. J Thorac Oncol. 2015 May;10(5):844-851 - PubMed
  15. Lancet. 2016 Apr 2;387(10026):1405-1414 - PubMed
  16. J Med Chem. 2006 Nov 2;49(22):6465-88 - PubMed
  17. Mol Cell Proteomics. 2012 Sep;11(9):651-68 - PubMed
  18. Carcinogenesis. 2012 May;33(5):969-75 - PubMed
  19. Br J Cancer. 2003 May 19;88(10):1553-9 - PubMed
  20. Cancers (Basel). 2019 Jun 19;11(6): - PubMed
  21. Clin Cancer Res. 2012 Sep 1;18(17):4485-90 - PubMed
  22. J Cell Sci. 2009 Apr 15;122(Pt 8):1059-69 - PubMed
  23. Oncoscience. 2018 Aug 28;5(11-12):278-280 - PubMed
  24. J Biol Chem. 2001 Mar 16;276(11):8544-9 - PubMed
  25. Int J Oncol. 2007 Dec;31(6):1501-8 - PubMed
  26. Virology. 1991 Jun;182(2):423-9 - PubMed
  27. Nat Rev Cancer. 2004 Feb;4(2):118-32 - PubMed
  28. Lancet Respir Med. 2019 Feb;7(2):99 - PubMed
  29. Carcinogenesis. 1994 Nov;15(11):2673-5 - PubMed
  30. Clin Cancer Res. 2002 Jul;8(7):2430-6 - PubMed
  31. Cancer Biol Ther. 2018 Apr 3;19(4):316-327 - PubMed
  32. Leukemia. 2008 Jan;22(1):161-9 - PubMed
  33. J Thorac Oncol. 2015 Apr;10(4):565-76 - PubMed
  34. Crit Rev Oncol Hematol. 2016 Aug;104:9-20 - PubMed
  35. Anticancer Agents Med Chem. 2017;17(10):1351-1356 - PubMed
  36. Nat Rev Cancer. 2016 Apr;16(4):201-18 - PubMed
  37. Sci Transl Med. 2014 May 21;6(237):237ra68 - PubMed
  38. Exp Ther Med. 2011 Jul;2(4):719-724 - PubMed
  39. J Biol Chem. 2003 May 2;278(18):15789-93 - PubMed
  40. Mol Cell Biol. 2000 Sep;20(18):6779-98 - PubMed
  41. Blood. 2007 Dec 1;110(12):4055-63 - PubMed
  42. J Adv Res. 2015 May;6(3):319-30 - PubMed
  43. Nature. 1976 Mar 11;260(5547):170-3 - PubMed
  44. Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6579-84 - PubMed
  45. Nature. 2006 Jan 19;439(7074):353-7 - PubMed
  46. Cell. 2007 Jan 26;128(2):281-94 - PubMed
  47. Cell Cycle. 2012 Mar 1;11(5):1029-39 - PubMed
  48. Oncotarget. 2017 Jul 18;8(29):47931-47942 - PubMed
  49. Front Pharmacol. 2016 Nov 07;7:416 - PubMed
  50. Cancer Res. 2019 Aug 15;79(16):4113-4123 - PubMed
  51. J Thorac Oncol. 2012 Apr;7(4):755-9 - PubMed
  52. Biochem J. 2007 Dec 15;408(3):297-315 - PubMed
  53. Eur J Cardiothorac Surg. 2010 Mar;37(3):566-72 - PubMed
  54. Oncogene. 2012 Feb 16;31(7):929-38 - PubMed
  55. J Immunother Cancer. 2017 Jul 18;5(1):53 - PubMed
  56. Nat Commun. 2017 Apr 24;8:15059 - PubMed
  57. Int J Cancer. 2001 Mar 1;91(5):638-43 - PubMed
  58. Oncologist. 2009 Jul;14(7):667-78 - PubMed
  59. Genes Dev. 1999 Jun 15;13(12):1501-12 - PubMed
  60. Int J Mol Sci. 2019 Sep 24;20(19): - PubMed
  61. Genome Biol. 2007;8(11):R255 - PubMed
  62. Genes Cancer. 2010 May 1;1(5):493-505 - PubMed
  63. Nat Commun. 2019 Mar 22;10(1):1333 - PubMed
  64. J Thorac Oncol. 2016 Feb;11(2):142-54 - PubMed
  65. PLoS One. 2013;8(2):e56505 - PubMed
  66. Clin Cancer Res. 2014 Apr 1;20(7):1846-55 - PubMed
  67. Clin Pharmacokinet. 2016 Oct;55(10):1191-1204 - PubMed
  68. Eur Respir J. 2020 Jun 11;55(6): - PubMed
  69. Curr Biol. 2015 Dec 7;25(23):3019-34 - PubMed
  70. Oncogene. 2019 May;38(18):3521-3534 - PubMed
  71. J Biol Chem. 2001 Aug 24;276(34):31858-62 - PubMed
  72. Mol Cancer Ther. 2007 Jul;6(7):1962-72 - PubMed
  73. Oncogene. 2002 Nov 7;21(51):7797-807 - PubMed
  74. Oncol Rep. 2012 Nov;28(5):1889-93 - PubMed
  75. J Hematol Oncol. 2019 Dec 30;12(1):144 - PubMed
  76. FEBS J. 2020 Jan;287(1):190-204 - PubMed
  77. Ann N Y Acad Sci. 2018 Nov;1431(1):72-84 - PubMed
  78. Oncol Rep. 2015 Nov;34(5):2305-10 - PubMed
  79. Mol Cancer Ther. 2014 Jan;13(1):82-9 - PubMed
  80. Oncotarget. 2015 Apr 30;6(12):10175-94 - PubMed
  81. Biochem Biophys Res Commun. 2014 May 16;447(4):609-15 - PubMed
  82. Mol Cancer Ther. 2016 Jul;15(7):1535-44 - PubMed
  83. Oncogene. 2000 Nov 16;19(48):5419-27 - PubMed
  84. Br J Cancer. 2014 May 13;110(10):2479-88 - PubMed
  85. Nat Chem Biol. 2010 Apr;6(4):291-9 - PubMed
  86. Nat Genet. 2011 Aug 28;43(10):1022-5 - PubMed
  87. J Dev Biol. 2019 Apr 08;7(2): - PubMed
  88. Pharmacol Res. 2015 Oct;100:250-4 - PubMed
  89. Cells. 2019 Sep 24;8(10): - PubMed
  90. Oncogene. 2005 Sep 8;24(40):6080-9 - PubMed
  91. Adv Drug Deliv Rev. 2011 Jul 18;63(8):610-5 - PubMed
  92. Prog Histochem Cytochem. 2012 Mar;47(1):27-58 - PubMed
  93. Ann Oncol. 2008 Aug;19(8):1379-1386 - PubMed
  94. Growth Factors. 2005 Dec;23(4):263-72 - PubMed
  95. J Thorac Oncol. 2018 May;13(5):606-623 - PubMed
  96. Trends Pharmacol Sci. 2012 Mar;33(3):122-8 - PubMed
  97. Oncogene. 2006 Aug 3;25(33):4585-94 - PubMed
  98. Oncologist. 2011;16(5):566-78 - PubMed
  99. Cold Spring Harb Perspect Biol. 2017 Jul 5;9(7): - PubMed
  100. Mol Oncol. 2020 Jun;14(6):1207-1223 - PubMed
  101. Histopathology. 2001 Jun;38(6):535-41 - PubMed
  102. J Biol Chem. 1995 May 26;270(21):12751-61 - PubMed
  103. Oncogene. 2014 Aug 14;33(33):4193-202 - PubMed
  104. Cancer Cell. 2016 Oct 10;30(4):610-622 - PubMed
  105. Int J Cancer. 2008 Aug 15;123(4):801-9 - PubMed
  106. Cell Death Differ. 2009 Aug;16(8):1146-55 - PubMed
  107. J Cell Physiol. 2011 Jan;226(1):236-47 - PubMed
  108. J Thorac Oncol. 2020 Jan;15(1):29-49 - PubMed
  109. Br J Cancer. 2018 Mar 20;118(6):770-776 - PubMed
  110. Cancers (Basel). 2017 Jun 18;9(6): - PubMed
  111. Cancer Sci. 2015 Dec;106(12):1651-8 - PubMed
  112. Invest New Drugs. 2013 Aug;31(4):967-73 - PubMed
  113. J Cell Biochem. 2015 May;116(5):856-63 - PubMed
  114. Cold Spring Harb Perspect Biol. 2018 Nov 1;10(11): - PubMed
  115. Front Biosci (Landmark Ed). 2012 Jun 01;17:2059-69 - PubMed
  116. Apoptosis. 2006 Oct;11(10):1825-35 - PubMed
  117. J Thorac Oncol. 2018 Nov;13(11):1655-1667 - PubMed
  118. J Pharmacol Sci. 2009 Aug;110(4):466-75 - PubMed
  119. Clin Cancer Res. 2007 Jul 15;13(14):4233-44 - PubMed
  120. Life Sci. 2009 May 8;84(19-20):650-6 - PubMed
  121. Oncotarget. 2016 Nov 22;7(47):76577-76589 - PubMed
  122. J Exp Med. 2018 Mar 5;215(3):859-876 - PubMed
  123. Nat Biotechnol. 2007 Sep;25(9):1035-44 - PubMed
  124. J Thorac Oncol. 2018 Feb;13(2):246-257 - PubMed
  125. Mol Biol Cell. 2007 Aug;18(8):3214-23 - PubMed
  126. Int J Cancer. 2012 Jun 1;130(11):2693-702 - PubMed
  127. Cancer Cell. 2017 Apr 10;31(4):563-575.e5 - PubMed
  128. Mol Immunol. 2004 Jul;41(6-7):631-43 - PubMed
  129. J Cell Physiol. 2017 Jan;232(1):129-35 - PubMed
  130. Oncotarget. 2015 May 20;6(14):12421-35 - PubMed
  131. J Cell Mol Med. 2020 May;24(10):5565-5577 - PubMed
  132. Am J Respir Crit Care Med. 2019 Oct 1;200(7):888-899 - PubMed
  133. Front Oncol. 2020 Mar 25;10:388 - PubMed
  134. Cancer Biother Radiopharm. 2017 Nov;32(9):320-326 - PubMed
  135. Dev Cell. 2013 Mar 11;24(5):447-58 - PubMed
  136. Biofactors. 2017 Nov;43(6):801-811 - PubMed
  137. Cancer Res. 2007 Mar 1;67(5):2226-38 - PubMed
  138. Future Oncol. 2017 Dec;13(28):2537-2546 - PubMed
  139. Cancer Lett. 2016 Oct 10;381(1):133-7 - PubMed
  140. BMC Cancer. 2013 May 30;13:269 - PubMed
  141. J Cell Biol. 2003 Mar 3;160(5):753-67 - PubMed
  142. Nat Rev Cancer. 2004 Jun;4(6):470-80 - PubMed
  143. Oncogene. 2006 Sep 28;25(44):5960-8 - PubMed
  144. Cell Death Dis. 2014 Apr 10;5:e1167 - PubMed
  145. Cancer. 2001 Sep 1;92(5):1245-50 - PubMed
  146. CA Cancer J Clin. 2018 Nov;68(6):394-424 - PubMed
  147. Cell Mol Bioeng. 2019 Feb;12(1):1-14 - PubMed
  148. Oncogene. 2018 Jul;37(27):3657-3671 - PubMed
  149. J Transl Med. 2014 May 27;12:148 - PubMed
  150. Int J Mol Sci. 2018 May 30;19(6): - PubMed
  151. Eur J Med Chem. 2019 Nov 1;181:111545 - PubMed
  152. J Toxicol Environ Health B Crit Rev. 2016;19(5-6):231-249 - PubMed
  153. Cell Death Differ. 2018 Mar;25(3):486-541 - PubMed
  154. Cancer Lett. 2019 Feb 1;442:271-278 - PubMed
  155. Br J Cancer. 2009 Nov 17;101(10):1699-708 - PubMed
  156. J Med Chem. 2004 Dec 30;47(27):6658-61 - PubMed
  157. Med Electron Microsc. 2002 Mar;35(1):16-23 - PubMed
  158. Expert Opin Investig Drugs. 2010 Aug;19(8):931-45 - PubMed
  159. Nat Genet. 2004 May;36(5):453-61 - PubMed
  160. Onco Targets Ther. 2019 Jan 18;12:635-645 - PubMed
  161. Breast Cancer Res Treat. 2007 Nov;105(3):319-26 - PubMed
  162. Lancet. 2005 Jul 30-Aug 5;366(9483):397-408 - PubMed
  163. Carcinogenesis. 1993 Aug;14(8):1597-602 - PubMed
  164. J Biochem. 2012 Jan;151(1):47-55 - PubMed
  165. Int J Biol Sci. 2012;8(10):1385-97 - PubMed
  166. Cell Death Dis. 2016 Dec 29;7(12):e2572 - PubMed
  167. Nat Rev Cancer. 2008 Apr;8(4):253-67 - PubMed

Publication Types

Grant support